We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisers Urge Approval of Two New Hepatitis C Treatments
FDA Advisers Urge Approval of Two New Hepatitis C Treatments
October 25, 2013
The FDA’s Antiviral Drugs Advisory Committee last week overwhelmingly recommended approval of two hepatitis C drug candidates — Janssen’s simeprevir and Gilead Sciences’ sofosbuvir.